Yi-Bin Chen

69PUBLICATIONS
323CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Cardiovascular medicine and haematology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (69)

|Oct 19, 2026
Prophylactic IFN-γ blockade drives axi-cel expansion without preventing refractory toxicities: caution against pre-emptive use.

|Sep 22, 2026
How I Treat: MRD testing to personalize allogeneic HCT for adults with AML.

|Jul 30, 2026
Regional practice differences significantly affect the benefit of post-HCT gilteritinib in FLT3-ITD AML.

|May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM.

|Apr 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

Pageof 12

Frequent Collaborators

33 joint publications

Zachariah DeFilipp

11 joint publications

John E Levine

10 joint publications

Elizabeth O Hexner

9 joint publications

Mark J Levis